I
Quinlones: Mostly all cover it..marginally.
I learned Cipro was the only anti-pseudomonal quinolone.
I just looked in Sanford and Cipro is the only (+). However, (+) means >60% susceptibility - IDSA says 80%.
Both moxi and levo were +/-
nope, not doing my homework - I'm out of school and practicing. I just have a hard time remembering these important ID things. thanks!
Quinlones: Mostly all cover it..marginally.
Not Moxi! Cipro is about the only one I see used for this.
The institution where I did my hospital rotations switched from Cipro/Levo to Cipro/Moxi, only using Cipro for pseudomonas and UTIs.
Do you know why that hospital switched to Cipro/Moxi?
Because the moxi reps came in and twisted their arms until they cried "Uncle!"
Levo is more expensive than moxi. 😀
No.. Moxi only has one strength.. and it costs $10 to $12 on contract and $35 non contract.
Levo 250mg costs around $5 to $7.. 500mg costs $7 to $12 and 750mg costs less than 500mg.. IVs.. so if you average it out..there is not a whole lot of difference in cost between Levo and Moxi..
So, try again. Why did that hospital switch to Moxi/cipro.. wanna be resident?
Well, they did mention the cost savings, and maybe it had to do with whatever contract they had.
Moxi instead of levo provides better anaerobic coverage and there is no renal dosing adjustment necessary with moxi.
Are you questioning me grasshopper? Well...why do you suppose they call cipro the "only" antipseudomonal? Hint... look at the indication.
Then again, look at the antibiogram..you'll notice that pseudomonal coverage between Levo and Cipro are more similar than different.
You should be proud that I'm questioning you!
Go read the job offer thread and give us advice there!
No.. Moxi only has one strength.. and it costs $10 to $12 on contract and $35 non contract.
Levo 250mg costs around $5 to $7.. 500mg costs $7 to $12 and 750mg costs less than 500mg.. IVs.. so if you average it out..there is not a whole lot of difference in cost between Levo and Moxi..
So, try again. Why did that hospital switch to Moxi/cipro.. wanna be resident?
Moxi got an indication for intraabdominal as monotherapy.
But you couldn't use Moxi on patients with both CAP and UTI where you can with Levo.. and do you really want to use Moxi for anaerobic infxns?
And renal dosing with Levaquin saves money...you lose out on cost savings opportunity with moxi because you don't renal dose it.
So try again...why did they switch to Moxi/Cipro from Levo?
Who do I get to play tonight...Ortho-McNeil or Schering-P drug rep?
And what are we talking about re: UTI...pseudomonas or E.coli, etc.
To remember all of that ID stuff I highly recommend the book "Clinical Microbiology Made Incredibly Simple." It saved my rear on our ID therapeutics exam.
Are you lost?
Lost?
No...just joking that a response would be different based on which "drug rep" you asked...
Everything from anaerobic coverage/aspiration pneumonia/C. diff outbreak costs, yada yada.
UTI comment had to do with ruling out Moxiflox. Which isn't necessarily applicable with E. Coli/enterococcus, but if we're talking psuedomonas empiric/formulary decisions, then forget about it, it's a non-issue.
Posted via Mobile BlackBerry Device
What kind of person types this much on a blackberry. And I only get this type of response from students who aren't sure of the answer..
But what kind of institution would make this sort of drastic formulary change based on how to treat UTI??
Exactly; you wouldn't...I didn't read the wholet hread and just thought you were talking strictly coverage. Avelox/UTI would just be an interesting conversation point for pseudomonas...but forget it if w'ere talking formulary.
I'm at a meeting, and bored...and have fast thumbs.
Posted via Mobile BlackBerry Device
You give up so easily... and what kind of company has a meeting at 9:20pm??????
Meeting between sales and ops regarding upcoming changes...joy.
Posted via Mobile BlackBerry Device
zeftera
straight off wikipedia, the drug reference of choice for pharmacy students
Ceftobiprole (brand name Zeftera) is a next generation cephalosporinantibiotic with activity against methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, Pseudomonas aeruginosa, and Enterococci.[2][3][4] It was discovered by Basilea Pharmaceutica[5] and was developed by Johnson & Johnson Pharmaceutical Research and Development.[6] It has been shown to be statistically non-inferior to the combination of vancomycin and ceftazidime for the treatment of skin and soft tissue infections.
Fabulous...another Z named-drug for Z to love.
Posted via Mobile BlackBerry Device
I don't like drugs that start with Z...

No Zocor for you? How about Zyprexa?![]()
![]()
I don't like drugs that start with Z...
What are you, on sarcasm receptor blocker?
Yeay...finally, I get to go home.
Posted via Mobile BlackBerry Device
oooooh.. I like that. SRB!!! Make that ZRB.. Zarcasm Receptor Blocker!
Get off your ZRB!!!
Threads like "Is pharmacy a complete profession? come in" are zarcasm receptor agonists.![]()

ID was never my strong point. . . (I am more into cardio/geriatric/antipsychotics). Can you explain to me why Cipro is sooo much better than Levo maybe with the exception of respiratory pneumonia? Thanks a bunch.
oooooh.. I like that. SRB!!! Make that ZRB.. Zarcasm Receptor Blocker!
Get off your ZRB!!!
Well, I'm answering one of my questions no one answered. Cipro, considered one of the earlier generation of quinolones tends to have a slight better coverage against Pseudomonas. So, cipro has an indication for Nosocomial pneumonia while other quinlones don't. But cipro's coverage against streptococcus pneumoniae isn't quite so good where Levo and Moxi usually have 100% sensitivity. So Cipro is a No No for community acquired pneumonia while good for Nosocomial.
But in real practice, I would never recommend Cipro for HAP or VAP.
Now.. pneumonia is usually "respiratory."![]()
Moxi = no UTI indication..
Hence no renal adjustment -- doesn't concentrate in the urine like other FQs
Nuh uhhhh...you can't have it. I've patented it. ZRB 😀
Are you saying Moxi's renal concentration isn't high enough to treat simple UTI with E. Coli?
I say why not? (Assuming E. coli as solo isolate and, again, not talking empiric...)